Table 1.
Clinical characteristics of the cohort of 619 infertile patients.
| HPV + patients |
||||
|---|---|---|---|---|
| Parameters | HPV − patients (N = 440) (Mean ± SD) |
HPV + patients (N = 179) (Mean ± SD) |
Seroconverted (N = 19/179) (Mean ± SD) |
Seronegative (N = 160/179) (Mean ± SD) |
| Age (years) | 38.2 ± 8.1 | 37.1 ± 7.4 | 40.3 ± 7.9 | 39.0 ± 9.1 |
| HPV + Female partner (N) | 174 (39.5%) | 150 (83.8%)a | 17 (89.5%)a | 133 (83.1%)a |
| Sperm concentration (× 106/mL) | 35.9 ± 8.4 | 30.4 ± 13.1 | 29.9 ± 7.9 | 33.4 ± 15.2 |
| Total sperm count (× 106) | 112.5 ± 38.7 | 92.9 ± 40.3 | 90.7 ± 42.6 | 93.4 ± 39.8 |
| Progressive motility (%) | 39.3 ± 12.1 | 22.7 ± 13.4a | 15.4 ± 9.5a,b | 23.1 ± 14.2a |
| Normal morphology (%) | 17.4 ± 5.3 | 14.9 ± 8.7 | 14.8 ± 10.0 | 15.1 ± 8.9 |
| Viability (%) | 85.1 ± 6.4 | 74.9 ± 9.8 | 75.2 ± 7.7 | 74.4 ± 10.1 |
| Positive SpermMar test (N) | 32 (18.0%) | 88 (49.2%)a | 18 (94.7%)a,b | 70 (43.8%)a |
Abbreviations: HPV +: patients with positive detection of HPV-DNA in semen; HPV −: patients with negative detection of HPV-DNA in semen; SD: standard deviation of the mean. Significance: a = P < 0.05 vs HPV-patients; b = P < 0.05 vs HPV + seronegative patients.